Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

5.110 +0.270 (+5.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Cathie Wood's Ark Invest Continues To Sell Shopify Shares Amid Q2 Ripples
Via Benzinga
Cathie Wood's Ark Invest Buys $16M Worth Of Shares Of Flying Taxi Company Archer Aviation — Sells Shopify Stock Worth Millions
Via Benzinga
These 9 AI Stocks Are Up 95%, On Average, Since End Of April
Nine artificial intelligence and AI-related stocks, with market caps in excess of $2B, have advanced by +60% since the bubble began to develop at the end of April into early May, with an average... 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Every AI Stock Cathie Wood Owns, Ranked From Best to Worst
You can find some great AI investment opportunities by looking at the stocks in Wood's Ark Invest portfolio. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Analyst Expectations for Recursion Pharmaceuticals's Future
Via Benzinga
3 Things About Recursion Pharmaceuticals That Smart Investors Know
Until it can get some recurring revenue going, it'll be a risky stock to buy. 
Via The Motley Fool
3 AI Stocks You’ll Regret Not Buying Soon
AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in. 
Via InvestorPlace
Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds
Recursion has predicted the protein target(s) for approximately 36 billion chemical compounds in the Enamine REAL Space, reported to be the world’s largest searchable chemical library. These advances... 
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results
From Recursion Pharmaceuticals
Via GlobeNewswire
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
Via Benzinga
2 Healthcare AI Stocks That Could Go Parabolic
Shares of Recursion Pharmaceuticals and GE Healthcare are both up sharply so far this year. 
Via The Motley Fool
Recursion to Participate in Upcoming Investor Conference
From Recursion Pharmaceuticals
Via GlobeNewswire
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
These 10 AI Stocks Are Up An Average Of 99% In Last 3 Months
Ten artificial intelligence and AI-related (AI&R) stocks, with market capitalizations of +$1.5B, have advanced by 70% or more (average of 99%!) since the bubble began to develop at the end of April.... 
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential
A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Exscientia is the Sniper of the AI Drug Discovery Industry
News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia’s AI Explosion: What NVDA Stock Investors Need to Know Now
Rather than sell your Nvidia shares, diversify. That's what the Cloud Czars want to do. They'll save, and you'll profit. 
Via InvestorPlace
Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships
Valence Labs is Recursion’s new machine learning research center that aims to promote open science and academic research. $1 million will be committed to advancing the next generation of academic... 
From Recursion Pharmaceuticals
Via GlobeNewswire
These 26 AI Stocks Are Up 58% In Just 11 Weeks
The Bank of America suggests that this is just a 
Via Talk Markets
MarketBeat Week in Review – 7/17 - 7/21
Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
3 Cutting-Edge Biotech Stocks That Are Riding the AI Wave Like None Other
They're not guaranteed to keep soaring, but they are right now. 
Via The Motley Fool
Did Nvidia Just Trigger a Short Squeeze in RXRX Stock?
Recursion Pharmaceuticals continues to rally higher, with RXRX stock now up more than 100% after Nvidia invested in the firm last week. 
Via InvestorPlace
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why It May Not Be Too Late to Join Nvidia’s Sky-High AI Rally
As long as Nvidia is a darling of the market - and as long as the company invests in future-facing technology - NVDA stock has room to run. 
Via InvestorPlace
Better AI Biotech Stock: Schrödinger vs. Recursion Pharmaceuticals
Both companies could tap into huge growth from the AI revolution in a few years. 
Via The Motley Fool
NVIDIA Just Invested $50 Million in This Biotech -- Should You Buy It?
Gaining one of the world's most important AI companies as a collaborator is huge. 
Via The Motley Fool
NVDA Stock Update: What Nvidia Investors Need to Be Watching Now
With Nvidia still the best option for long-term investors looking to take advantage of the AI race, here's what to watch. 
Via InvestorPlace
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks
Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%. 
Via Talk Markets
Nvidia Invested $50 million into This AI Drug Discovery Biotech
Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.